Objective:To compare oxytocin infusion with control, in patients undergoing abdominal myomectomy in terms of mean blood loss.
Design: Single blinded randomized control trial Setting: Obstetrics and Gynecology Department, Military Hospital, Rawalpindi Population: 60 women of ASA class I-II, with intramural fibroids, candidate for elective abdominal myomectomy.
Methods: Women were divided into two groups randomly. In the study group 30 Units of oxytocin in 1000 ml normal saline were given during surgery, at the rate of 15units/hour. In control group, pure normal saline was given.
Main outcome measure: Intra-operative blood loss
Full Title of Study: “Effect of Oxytocin Infusion on Reducing the Blood Loss During Abdominal Myomectomy: A Randomized Controlled Trial”
- Study Type: Interventional
- Study Design
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Primary Purpose: Prevention
- Masking: Single (Participant)
- Study Primary Completion Date: January 15, 2018
- Other: oxytocin in abdominal myomectomy
- Women were divided into two groups randomly. In the study group 30 Units of oxytocin in 1000 ml normal saline were given during surgery, at the rate of 15units/hour. In control group, pure normal saline was given
Arms, Groups and Cohorts
- Experimental: study group
- No Intervention: control group
Clinical Trial Outcome Measures
- Intra-operative blood loss
- Time Frame: during the surgical procedure
- average intra operative blood loss was measured
Participating in This Clinical Trial
1. women of ASA class I-II with intramural fibroids,
2. women planned to undergo elective abdominal myomectomy
1. Women with hemoglobin (Hb) < 10g/dl
2. Women with any respiratory or cardiovascular disease.
Gender Eligibility: Female
Minimum Age: 25 Years
Maximum Age: 40 Years
Are Healthy Volunteers Accepted: No
- Lead Sponsor
- Armed Forces Hospital, Pakistan
- Provider of Information About this Clinical Study
- Principal Investigator: arshad khushdil, Assistant professor – Armed Forces Hospital, Pakistan
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.